_id
690daf1bccc777a4e85d0ade
Ticker
ANPCF
Name
ANGLE plc
Exchange
OTCQX
Address
Surrey Research Park, Guildford, United Kingdom, GU2 7AF
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://cellbxhealth.com
Description
CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis; and Parsortix PR1 system captures and harvests circulating tumour cells from blood. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal circulating tumour cells; and CellKeep Slide, a CTC harvesting technology. In addition, the company offers laboratory services, including CTC enrichment and liquid biopsy analysis services; Portrait Flex, an immunofluorescence assay for the identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition; DNA damage response; Portrait PD-L1, evaluates CTCs; and custom CTC assays. CelLBxHealth plc has a strategic partnership with BioView Ltd to develop a human epidermal growth factor receptor 2 assay kit for breast cancer; and agreement with NuProbe USA, Inc. to use pan-cancer next generation sequencing (NGS) panel. The company was formerly known as ANGLE plc and changed its name to CelLBxHealth plc in October 2025. CelLBxHealth plc was founded in 1994 and is based in Guildford, the United Kingdom.
Last Close
0.025
Volume
10000
Current Price
0.0168
Change
0
Last Updated
2026-01-20T15:25:56.944Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
32708934
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
1946960389
Income Tax Expense
-399500
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
22162000
Short Term Investments
-
Receivables
1436000
Inventories
2256000
Total Current Assets
29529000
Property Plant Equipment
7887000
Total Assets
40164000
Payables
2882000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
8096000
Equity
32068000
Bs_currency_symbol
GBP
Depreciation
437500
Change In Working Capital
-
Cash From Operations
-4502500
Capital Expenditures
189000
Cash From Investing
-105500
Cash From Financing
-270500
Net Change In Cash
-4867000
Cf_currency_symbol
USD
PE
-
PB
0.13673523405263813
ROE
-
ROA
-
FCF
-4691500
Fcf Percent
-
Piotroski FScore
0
Health Score
59
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
2.5
Garp Investing Score
1.5
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
3.5
Quality Investing Score
2
Value Investing Score
6
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
261001517
Quarters > 0 > income Statement > income Tax Expense
-399500
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
22162000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1436000
Quarters > 0 > balance Sheet > inventories
2256000
Quarters > 0 > balance Sheet > total Current Assets
29529000
Quarters > 0 > balance Sheet > property Plant Equipment
7887000
Quarters > 0 > balance Sheet > total Assets
40164000
Quarters > 0 > balance Sheet > payables
2882000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
8096000
Quarters > 0 > balance Sheet > equity
32068000
Quarters > 0 > balance Sheet > currency_symbol
GBP
Quarters > 0 > cash Flow > net Income
-4906500
Quarters > 0 > cash Flow > depreciation
437500
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-4502500
Quarters > 0 > cash Flow > capital Expenditures
189000
Quarters > 0 > cash Flow > cash From Investing
-105500
Quarters > 0 > cash Flow > cash From Financing
-270500
Quarters > 0 > cash Flow > net Change In Cash
-4867000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
0.13673523405263813
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-4691500
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
59
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-399500
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
5111000
Quarters > 1 > balance Sheet > inventories
2256000
Quarters > 1 > balance Sheet > total Current Assets
29529000
Quarters > 1 > balance Sheet > property Plant Equipment
7887000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
2882000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3934000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-4906500
Quarters > 1 > cash Flow > depreciation
437500
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-4502500
Quarters > 1 > cash Flow > capital Expenditures
189000
Quarters > 1 > cash Flow > cash From Investing
-105500
Quarters > 1 > cash Flow > cash From Financing
-270500
Quarters > 1 > cash Flow > net Change In Cash
-4867000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-4691500
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2022-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
261001517
Quarters > 2 > income Statement > income Tax Expense
-735000
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
31896000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
317000
Quarters > 2 > balance Sheet > inventories
2059000
Quarters > 2 > balance Sheet > total Current Assets
38628000
Quarters > 2 > balance Sheet > property Plant Equipment
8476000
Quarters > 2 > balance Sheet > total Assets
49868000
Quarters > 2 > balance Sheet > payables
1495000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
9805000
Quarters > 2 > balance Sheet > equity
40063000
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-6232500
Quarters > 2 > cash Flow > depreciation
526500
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-2984000
Quarters > 2 > cash Flow > capital Expenditures
401000
Quarters > 2 > cash Flow > cash From Investing
-397500
Quarters > 2 > cash Flow > cash From Financing
9220000
Quarters > 2 > cash Flow > net Change In Cash
5699500
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
0.10944825613658488
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-3385000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
59
Quarters > 3 > quarter
2022-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
-735000
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
3711000
Quarters > 3 > balance Sheet > inventories
2059000
Quarters > 3 > balance Sheet > total Current Assets
38628000
Quarters > 3 > balance Sheet > property Plant Equipment
8476000
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
1495000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
5250000
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-6232500
Quarters > 3 > cash Flow > depreciation
526500
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-2984000
Quarters > 3 > cash Flow > capital Expenditures
401000
Quarters > 3 > cash Flow > cash From Investing
-397500
Quarters > 3 > cash Flow > cash From Financing
9220000
Quarters > 3 > cash Flow > net Change In Cash
5699500
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-3385000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2862000
Annuals > 0 > income Statement > cost Of Revenue
1083000
Annuals > 0 > income Statement > gross Profit
1779000
Annuals > 0 > income Statement > operating Expenses
18336000
Annuals > 0 > income Statement > operating Income
-15474000
Annuals > 0 > income Statement > interest Expense
307000
Annuals > 0 > income Statement > pretax Income
-15029000
Annuals > 0 > income Statement > net Income
-14225000
Annuals > 0 > income Statement > eps
-0.04410464195729189
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
322528409
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-540.670859538784
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
10425000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
774000
Annuals > 0 > balance Sheet > inventories
1579000
Annuals > 0 > balance Sheet > total Current Assets
16408000
Annuals > 0 > balance Sheet > property Plant Equipment
6402000
Annuals > 0 > balance Sheet > total Assets
25458000
Annuals > 0 > balance Sheet > payables
695000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
7017000
Annuals > 0 > balance Sheet > equity
18441000
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-14225000
Annuals > 0 > cash Flow > depreciation
1698000
Annuals > 0 > cash Flow > change In Working Capital
-1132000
Annuals > 0 > cash Flow > cash From Operations
-13448000
Annuals > 0 > cash Flow > capital Expenditures
444000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-5828000
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.04410464195729189
Annuals > 0 > ratios > PB
0.29382773554579467
Annuals > 0 > ratios > ROE
-77.13789924624479
Annuals > 0 > ratios > ROA
-55.87634535313065
Annuals > 0 > ratios > FCF
-13892000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-4.853948287910552
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2186000
Annuals > 1 > income Statement > cost Of Revenue
658000
Annuals > 1 > income Statement > gross Profit
1528000
Annuals > 1 > income Statement > operating Expenses
22644000
Annuals > 1 > income Statement > operating Income
-20458000
Annuals > 1 > income Statement > interest Expense
325000
Annuals > 1 > income Statement > pretax Income
-21632000
Annuals > 1 > income Statement > net Income
-20132000
Annuals > 1 > income Statement > eps
-0.07713365129598078
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
261001517
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-935.8645928636779
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
16218000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
727000
Annuals > 1 > balance Sheet > inventories
1679000
Annuals > 1 > balance Sheet > total Current Assets
21216000
Annuals > 1 > balance Sheet > property Plant Equipment
7226000
Annuals > 1 > balance Sheet > total Assets
31183000
Annuals > 1 > balance Sheet > payables
1059000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
8244000
Annuals > 1 > balance Sheet > equity
22939000
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-20132000
Annuals > 1 > cash Flow > depreciation
2308000
Annuals > 1 > cash Flow > change In Working Capital
-1031000
Annuals > 1 > cash Flow > cash From Operations
-14458000
Annuals > 1 > cash Flow > capital Expenditures
660000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-15786000
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.07713365129598078
Annuals > 1 > ratios > PB
0.19115155349404941
Annuals > 1 > ratios > ROE
-87.7631980469942
Annuals > 1 > ratios > ROA
-64.5608183946381
Annuals > 1 > ratios > FCF
-15118000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-6.915827996340347
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1041000
Annuals > 2 > income Statement > cost Of Revenue
428000
Annuals > 2 > income Statement > gross Profit
613000
Annuals > 2 > income Statement > operating Expenses
24820000
Annuals > 2 > income Statement > operating Income
-24207000
Annuals > 2 > income Statement > interest Expense
368000
Annuals > 2 > income Statement > pretax Income
-24439000
Annuals > 2 > income Statement > net Income
-21686000
Annuals > 2 > income Statement > eps
-0.0879472435283425
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
246579644
Annuals > 2 > income Statement > income Tax Expense
-2753000
Annuals > 2 > income Statement > EBITDA
-21233000
Annuals > 2 > income Statement > operating Margin
-2325.36023054755
Annuals > 2 > income Statement > total Other Income Expense Net
-232000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
31896000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1797000
Annuals > 2 > balance Sheet > inventories
2059000
Annuals > 2 > balance Sheet > total Current Assets
38628000
Annuals > 2 > balance Sheet > property Plant Equipment
8476000
Annuals > 2 > balance Sheet > total Assets
49868000
Annuals > 2 > balance Sheet > payables
3978000
Annuals > 2 > balance Sheet > short Term Debt
662000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
9805000
Annuals > 2 > balance Sheet > equity
40063000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-24439000
Annuals > 2 > cash Flow > depreciation
2838000
Annuals > 2 > cash Flow > change In Working Capital
-1614000
Annuals > 2 > cash Flow > cash From Operations
-16050000
Annuals > 2 > cash Flow > capital Expenditures
1887000
Annuals > 2 > cash Flow > cash From Investing
-1751000
Annuals > 2 > cash Flow > cash From Financing
18096000
Annuals > 2 > cash Flow > net Change In Cash
57000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-0.0879472435283425
Annuals > 2 > ratios > PB
0.10340059454359382
Annuals > 2 > ratios > ROE
-54.129745650600306
Annuals > 2 > ratios > ROA
-43.486805165637286
Annuals > 2 > ratios > FCF
-17937000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-17.230547550432277
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1013000
Annuals > 3 > income Statement > cost Of Revenue
302000
Annuals > 3 > income Statement > gross Profit
711000
Annuals > 3 > income Statement > operating Expenses
17946000
Annuals > 3 > income Statement > operating Income
-17235000
Annuals > 3 > income Statement > interest Expense
157000
Annuals > 3 > income Statement > pretax Income
-17363000
Annuals > 3 > income Statement > net Income
-15012000
Annuals > 3 > income Statement > eps
-0.06669824747822244
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
225073380
Annuals > 3 > income Statement > income Tax Expense
-2351000
Annuals > 3 > income Statement > EBITDA
-15719000
Annuals > 3 > income Statement > operating Margin
-1701.3820335636724
Annuals > 3 > income Statement > total Other Income Expense Net
-128000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
31839000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
5172000
Annuals > 3 > balance Sheet > inventories
1748000
Annuals > 3 > balance Sheet > total Current Assets
39366000
Annuals > 3 > balance Sheet > property Plant Equipment
4376000
Annuals > 3 > balance Sheet > total Assets
47315000
Annuals > 3 > balance Sheet > payables
4390000
Annuals > 3 > balance Sheet > short Term Debt
522000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
6985000
Annuals > 3 > balance Sheet > equity
40330000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-17363000
Annuals > 3 > cash Flow > depreciation
1487000
Annuals > 3 > cash Flow > change In Working Capital
606000
Annuals > 3 > cash Flow > cash From Operations
-14010000
Annuals > 3 > cash Flow > capital Expenditures
1788000
Annuals > 3 > cash Flow > cash From Investing
14774000
Annuals > 3 > cash Flow > cash From Financing
18991000
Annuals > 3 > cash Flow > net Change In Cash
19759000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.06669824747822244
Annuals > 3 > ratios > PB
0.09375732169600792
Annuals > 3 > ratios > ROE
-37.22291098437888
Annuals > 3 > ratios > ROA
-31.727781887350737
Annuals > 3 > ratios > FCF
-15798000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-15.595261599210266
Annuals > 3 > health Score
33
Valuation > metrics > PB
0.13673523405263813
Valuation > final Score
70
Valuation > verdict
86.3% Undervalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2524635150305601
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
10.246009715475365
Liquidity > metrics > Quick Ratio
9.46321998612075
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
80
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:23:32.430Z
Earnings History > 0 > period
2021-04-30
Earnings History > 0 > report Date
2021-06-30
Earnings History > 0 > date
2021-04-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
GBP
Earnings History > 0 > eps Actual
-0.0247
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.0247
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-01-31
Earnings History > 1 > report Date
2021-03-31
Earnings History > 1 > date
2021-01-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
GBP
Earnings History > 1 > eps Actual
-0.0246
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0246
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-10-31
Earnings History > 2 > report Date
2020-12-31
Earnings History > 2 > date
2020-10-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
GBP
Earnings History > 2 > eps Actual
-0.0255
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.0255
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-07-31
Earnings History > 3 > report Date
2020-09-30
Earnings History > 3 > date
2020-07-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
GBP
Earnings History > 3 > eps Actual
-0.0241
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0241
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-04-30
Earnings History > 4 > report Date
2020-06-30
Earnings History > 4 > date
2020-04-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
GBP
Earnings History > 4 > eps Actual
-0.0122
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.0122
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-01-31
Earnings History > 5 > report Date
2020-03-31
Earnings History > 5 > date
2020-01-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
GBP
Earnings History > 5 > eps Actual
-0.0122
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.0122
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-04-30
Earnings History > 6 > report Date
2019-06-30
Earnings History > 6 > date
2019-04-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
GBP
Earnings History > 6 > eps Actual
-0.0215
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0215
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-01-31
Earnings History > 7 > report Date
2019-04-30
Earnings History > 7 > date
2019-01-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
GBP
Earnings History > 7 > eps Actual
-0.0213
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.0213
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2018-10-31
Earnings History > 8 > report Date
2019-01-31
Earnings History > 8 > date
2018-10-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
GBP
Earnings History > 8 > eps Actual
-0.0215
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0215
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2018-01-31
Earnings History > 9 > report Date
2018-04-30
Earnings History > 9 > date
2018-01-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
GBP
Earnings History > 9 > eps Actual
-0.0244
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0244
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2017-10-31
Earnings History > 10 > report Date
2018-01-31
Earnings History > 10 > date
2017-10-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
GBP
Earnings History > 10 > eps Actual
-0.0252
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0252
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2017-07-31
Earnings History > 11 > report Date
2017-10-31
Earnings History > 11 > date
2017-07-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
GBP
Earnings History > 11 > eps Actual
-0.0305
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.0305
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2017-04-30
Earnings History > 12 > report Date
2017-07-31
Earnings History > 12 > date
2017-04-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
GBP
Earnings History > 12 > eps Actual
-0.0303
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0303
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2016-07-31
Earnings History > 13 > report Date
2016-10-31
Earnings History > 13 > date
2016-07-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
GBP
Earnings History > 13 > eps Actual
-0.0221
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0221
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2016-04-30
Earnings History > 14 > report Date
2016-07-31
Earnings History > 14 > date
2016-04-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
GBP
Earnings History > 14 > eps Actual
-0.0239
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0239
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-01-31
Earnings History > 15 > report Date
2016-04-30
Earnings History > 15 > date
2016-01-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
GBP
Earnings History > 15 > eps Actual
-0.034
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.034
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2015-10-31
Earnings History > 16 > report Date
2016-01-31
Earnings History > 16 > date
2015-10-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
GBP
Earnings History > 16 > eps Actual
-0.0329
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0329
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2015-07-31
Earnings History > 17 > report Date
2015-10-31
Earnings History > 17 > date
2015-07-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
GBP
Earnings History > 17 > eps Actual
-0.0287
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0287
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2015-04-30
Earnings History > 18 > report Date
2015-07-31
Earnings History > 18 > date
2015-04-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
GBP
Earnings History > 18 > eps Actual
-0.0291
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0291
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2015-01-31
Earnings History > 19 > report Date
2015-04-30
Earnings History > 19 > date
2015-01-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
GBP
Earnings History > 19 > eps Actual
-0.0327
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0327
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2014-10-31
Earnings History > 20 > report Date
2015-01-31
Earnings History > 20 > date
2014-10-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
GBP
Earnings History > 20 > eps Actual
-0.032
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.032
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2014-07-31
Earnings History > 21 > report Date
2014-10-31
Earnings History > 21 > date
2014-07-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
GBP
Earnings History > 21 > eps Actual
-0.0255
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0255
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2014-04-30
Earnings History > 22 > report Date
2014-07-31
Earnings History > 22 > date
2014-04-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
GBP
Earnings History > 22 > eps Actual
-0.027
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.027
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2013-07-31
Earnings History > 23 > report Date
2013-10-31
Earnings History > 23 > date
2013-07-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
GBP
Earnings History > 23 > eps Actual
-0.007
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.007
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2013-04-30
Earnings History > 24 > report Date
2013-07-31
Earnings History > 24 > date
2013-04-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
GBP
Earnings History > 24 > eps Actual
-0.0067
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.0067
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2013-01-31
Earnings History > 25 > report Date
2013-04-30
Earnings History > 25 > date
2013-01-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
GBP
Earnings History > 25 > eps Actual
-0.0109
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.0109
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2012-10-31
Earnings History > 26 > report Date
2013-01-31
Earnings History > 26 > date
2012-10-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
GBP
Earnings History > 26 > eps Actual
-0.0111
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.0111
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2012-07-31
Earnings History > 27 > report Date
2012-10-31
Earnings History > 27 > date
2012-07-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
GBP
Earnings History > 27 > eps Actual
-0.0056
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-0.0056
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2012-04-30
Earnings History > 28 > report Date
2012-07-31
Earnings History > 28 > date
2012-04-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
GBP
Earnings History > 28 > eps Actual
-0.0055
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.0055
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2012-01-31
Earnings History > 29 > report Date
2012-04-30
Earnings History > 29 > date
2012-01-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
GBP
Earnings History > 29 > eps Actual
-0.0186
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-0.0186
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2011-10-31
Earnings History > 30 > report Date
2012-01-31
Earnings History > 30 > date
2011-10-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
GBP
Earnings History > 30 > eps Actual
-0.0181
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-0.0181
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2011-07-31
Earnings History > 31 > report Date
2011-10-31
Earnings History > 31 > date
2011-07-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
GBP
Earnings History > 31 > eps Actual
-0.043
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.043
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2011-04-30
Earnings History > 32 > report Date
2011-07-31
Earnings History > 32 > date
2011-04-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
GBP
Earnings History > 32 > eps Actual
-0.0439
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.0439
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2011-01-31
Earnings History > 33 > report Date
2011-04-30
Earnings History > 33 > date
2011-01-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
GBP
Earnings History > 33 > eps Actual
-0.0076
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.0076
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2010-10-31
Earnings History > 34 > report Date
2011-01-31
Earnings History > 34 > date
2010-10-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
GBP
Earnings History > 34 > eps Actual
-0.0073
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-0.0073
Earnings History > 34 > surprise Percent
-
CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis; and Parsortix PR1 system captures and harvests circulating tumour cells from blood. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal circulating tumour cells; and CellKeep Slide, a CTC harvesting technology. In addition, the company offers laboratory services, including CTC enrichment and liquid biopsy analysis services; Portrait Flex, an immunofluorescence assay for the identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition; DNA damage response; Portrait PD-L1, evaluates CTCs; and custom CTC assays. CelLBxHealth plc has a strategic partnership with BioView Ltd to develop a human epidermal growth factor receptor 2 assay kit for breast cancer; and agreement with NuProbe USA, Inc. to use pan-cancer next generation sequencing (NGS) panel. The company was formerly known as ANGLE plc and changed its name to CelLBxHealth plc in October 2025. CelLBxHealth plc was founded in 1994 and is based in Guildford, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACelLBxHealth plans £6.8 million fundraise as it pushes for commercial reboot - Proactive Investors
11/25/2025
CelLBxHealth plans £6.8 million fundraise as it pushes for commercial reboot Proactive Investors
Read more →CellBxHealth rises on Qiagen tie-up to push Parsortix into more drug-development projects Proactive financial news
Read more →Showing 2 of 7
(Last Updated 2023-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of ANGLE plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2021-04-30
EPS Actual
-0.0247
EPS Estimate
0
EPS Difference
-0.0247
Surprise Percent
0%
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.